Related Experiment Video

Updated: May 21, 2025

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
10:29

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis

Published on: March 24, 2017

7.7K

Primary efficacy endpoints in phase 3 non-inferiority trials to establish new tuberculosis treatment regimens should

Tom A Yates1, Daniel J Grint2

  • 1Institute of Health Informatics, University College London, London, UK; Division of Infection and Immunity, University College London, London, UK.

The Lancet. Microbe
|March 18, 2025
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
06:26

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis

Published on: July 28, 2023

2.1K
System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
09:57

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

8.5K

Related Experiment Videos

Last Updated: May 21, 2025

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
10:29

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis

Published on: March 24, 2017

7.7K
Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
06:26

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis

Published on: July 28, 2023

2.1K
System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
09:57

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

8.5K

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

159
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
159
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

127
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
127
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

283
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
283

Articles linked to this work by shared authors, journal, and citation graph.

Imprecision in tuberculosis infection outcomes: implications for non-inferiority vaccine trials.

International journal of epidemiology·2026

Treatment Adherence With an Oral 9-Month Regimen for Rifampicin-Resistant Tuberculosis in South Africa.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026

The indirect effects of cytomegalovirus infection-mechanisms and consequences.

Philosophical transactions of the Royal Society of London. Series B, Biological sciences·2025

Intensified Treatment of Tuberculous Meningitis in Adults: A Systematic Review and Meta-analysis.

Open forum infectious diseases·2025

Do no harm - re-evaluating the risks of overtreatment in community-wide tuberculosis screening.

medRxiv : the preprint server for health sciences·2025

Xpert MTB/RIF Cycle Threshold as a Marker of Tuberculosis (TB) Disease Severity: Implications for TB Treatment Stratification.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2025

Importance of faecal sample collection in prospective cohort studies to evaluate the effect of the gut microbiome on cancer development.

The Lancet. Microbe·2026

Host and environmental factors associated with upper respiratory tract mycobiota in healthy individuals: a cross-sectional observational study.

The Lancet. Microbe·2026

MERS-CoV in Africa: a One Health review of the silent reservoir.

The Lancet. Microbe·2026

A competitive BB-ELISA for anti-toxin B neutralising antibodies in assessing risk of recurrent Clostridioides difficile infection: a retrospective cohort study from the MODIFY I and II trials.

The Lancet. Microbe·2026

Epidemiology and phylogenomic characterisation of the 2025 Ebola virus disease outbreak in Bulape, Kasaï province, Democratic Republic of the Congo: a retrospective observational study.

The Lancet. Microbe·2026

Evaluation of the laboratory assessment process for A Clinically Oriented Antimicrobial Resistance Surveillance Network (ACORN-LAP) in low-income and middle-income countries: a multicountry, cross-sectional analysis with longitudinal quality monitoring.

The Lancet. Microbe·2026

Single-Cell Membrane-Permeabilization Kinetics Reveal Species-Specific Responses to Antimicrobial Photodynamic Treatment.

ACS omega·2026

Hospital-Based Surveillance of Antimicrobial Resistance in Southern Brazil: Resistance Profiles and Phenotypic Carbapenemase Screening.

Indian journal of medical microbiology·2026

Antimicrobial resistance profiles and genomic diversity of vaginal Prevotella bivia isolates from South African women, including the first report of nimK in South African vaginal P. bivia isolates.

Anaerobe·2026

First reported human Castellaniella defragrans bacteraemia: a case report.

Swiss medical weekly·2026

Antibacterial activity of seawater-derived Bacillus subtilis strain SC2 and its bioactive fraction.

Archives of microbiology·2026

Highly- and Low-virulent Mycobacterium tuberculosis Strains of the Beijing Genotype Elicit Contrasting Immune Response in C57BL/6 Mice as Revealed by Inducible Nitric Oxide Synthase and Tumor Necrosis Factor-alpha Distinct Expression.

International journal of mycobacteriology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us